UCLA, PreciseDx to Develop AI-Powered Breast Cancer Recurrence Tool for Early Detection
What You Should Know: – PreciseDx®, a leader in AI-powered diagnostics for oncology, announces a crucial collaboration with UCLA’s Department of Pathology and Laboratory Medicine. – The research initiative focuses on evaluating PreciseDx’s innovative…
Continue Reading